allergic rhinitis
Conditions
Interventions
Group A:Cetirizine 10mg P.O. once daily, for 4 consecutive weeks
Group B:Acupuncture: points selection: Yingxiang(LI20), Yintang, Baihui (GV20),Hegu(LI4), Feishu(BL13), Pishu(BL20),Shenshu(BL23),Ganshu(BL18), Dazhui(GV14),Taichong(LR3).Yingxiang(LI20),Yintang and B
Sponsors
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Subject has experienced main symptoms (nasal congestion, rhinorrhea, sneezing and nasal itching)for more than 4 days a week and for more than 4 consecutive weeks; 2. Subject presenting moderate/severe condition meeting the diagnostic criteria; 3. Subject responding with positive skin test reaction to at least one inhaled allergen; 4. Subject shows a mean total nasal symptom score (TNSS)>=4 one week before acupuncture intervention; 5. Subject age ranges between 18 and 66 years old; 6. Subject is able to provide written informed consent.
Exclusion criteria
Exclusion criteria: 1. Patient has suffered from acute paranasal sinusitis or upper respiratory infection within the last 14 days; signs of chest inflammation showed in X-ray; 2. Patient with history of chronic paranasal sinusitis or chronic paranasal sinusitis showned by accessory nasal cavity X-ray examination; 3. Patient presenting organic nasal cavity disease or has undergone nasal cavity surgery; 4. Patient suffering from paroxysmal respiratory diseases such as asthma; 5. Patients taking H1 antihistamine, steroids, antihistamine, decongestant (nasal, oral or ophthalmic), corticosteroids, antibiotics, or prohibited medications listed in Appendix 1 within 14 days of enrollment; 6. Subject that received specific immunotherapy or systematic hormone therapy in the last year; 7. Subject that received acupuncture, moxibustion, cupping, nasal inhalation of herbal medicine, or other physical therapies in traditional medicine treatment within the last 14 days; 8. Subject that took herbal preparation for allergic rhinitis within the last 14 days; 9. Subject is pregnant, lactating or planning to become pregnant. 10. Subject suffering from tuberculosis, hepatitis, or with blood Cr, AST/ALT values twice higher than normal ranges; 11. Subject suffering from mental disorders; 12. Subject presenting with a smoking history of over 10 cigarettes daily, during 10 consecutive years; 13. Subject presenting scars on the needling location or suffering from systemic disease therefore being considered unsuitable for needling application; 14. Subject that has been estimated as unable to collaborate in the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total nasal symptom scores (TNSS); | — |
Secondary
| Measure | Time frame |
|---|---|
| Life Questionnaire (RQLQ);Total nonnasal symptom score (TNNSS); | — |
Countries
China
Contacts
Public ContactJiping Zhao
Acupuncture Department, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Outcome results
None listed